Wegovy
Weight Loss Medications Pose New Challenges for Benefit Leaders
With the surge in popularity of the GLP-1 receptor agonists Saxenda and Wegovy, and the recent FDA approval of ...
MARCH 5, 2024
Dangerous Market for Weight-Loss Drugs Grows Online
High demand and short supply of GLP-1 antagonists used to treat diabetes and obesity have led many people desperate ...
DECEMBER 19, 2023
Cardiovascular Benefit Could Pave The Way for Wider Use of Wegovy
Phase 3 clinical trial results demonstrating that semaglutide 2.4 mg reduces the incidence of major cardiovascular ...
NOVEMBER 23, 2023
Load more